SkiStar AB will publish the Interim Report for the period 1 September 2025 – 30 November 2025 on Thursday 18 December 2025 at 07.00 a.m. CET. In connection with the report SkiStar will organize a ...

“We are honored to accept the Innovators Award from Cabling Installation and Maintenance,” said Gary Portellas, Patton’s Sr. Product Manager for Connectivity. “Patton has been miniaturizing ...

Inderes’ revenue grew 15% in November 2025 and was 1.8 (1.6) MEUR. “November's revenue growth was based on strong growth in project revenue from the Events business. Particularly, the revenue from ...

As the energy and resources landscape undergoes rapid transformation in 2025, driven by geopolitical shifts, strategic industrial realignments and accelerating technology change, Wood Mackenzie has ...

The data support SVF Vaccines’ goal for SVF-001 to achieve strong and long-lasting immunological control of hepatitis B and hepatitis D in patients with chronic coinfections. The data was presented by ...

Chongqing, China, December 10, 2025 - Changan today celebrated a historic achievement as its 30 millionth vehicle-an AVATR 12 Quad-Laser Edition-rolled off the line at the AVATR Digital Intelligence ...

Event to be held virtually via live webcast and archived on www.genmab.com ...

Extensive clinical and real-world validation: Heartflow’s AI-driven solutions have been validated through clinical evidence in over 100 studies assessing over 365,000 patients. Proven in real-world ...

The financial sector’s capital position has remained strong, despite uncertainties. The list of risks in the operating environment continues to include geopolitical and trade risks as well as concerns ...

Under the partnership, Phare Bio will deploy its Generative AI platform to design molecules with antibacterial properties that meet a pre-defined target product profile, which considers both unmet ...

Zealand Pharma and OTR Therapeutics enter multi-program strategic collaboration and license agreement to develop novel therapeutics for metabolic ...

Aukera is focused on the therapy of neurological conditions associated with RAPTOR activity (regulatory-associated protein of mTOR). The company screened billions of compounds using AI-supported ...